• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Heart Fail . Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Eur J Heart Fail


. 2020 Jul 19.
doi: 10.1002/ejhf.1967. Online ahead of print.
Pathogenesis and Management of Myocardial Injury in Coronavirus Disease 2019


Zhi-Yao Wei[SUP] 1 [/SUP], Hai-Yan Qian[SUP] 1 [/SUP], Ji Huang[SUP] 2 [/SUP], Yong-Jian Geng[SUP] 3 [/SUP]



Affiliations

Abstract

The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a major health crisis and a worldwide pandemic. COVID-19 is characterized by high infectivity, long incubation period, diverse clinical presentations, and strong transmission intensity. COVID-19 can cause myocardial injury as well as other cardiovascular complications, particularly in senior patients with pre-existing medical conditions. The current review summarizes the epidemiological characteristics, potential mechanisms, clinical manifestations, and recent progress in the management of COVID-19 cardiovascular complications.

Keywords: COVID-19; SARS-CoV-2; blood vessels; heart; inflammation.
 
Back
Top Bottom